‹ ›
MYP_151439
← PREVIOUS NEXT → BACK
Basic Information
NS5A-derived peptide C5A [I6L]
Antimicrobial
Antiviral
Antiviral ▸ Anti-Hepatitis virus ▸ Anti-HCV
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Anti-HIV ▸ HIV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Venom / Toxin ▸ General toxin ▸ Toxic
Standard
18 amino acids
C109H155N25O29S
Standard
Sequence
SWLRDLWDWICEVLSDFK
Physicochemical Analysis
2311.61 Da
4.23
-2.54
-2.77
-0.1414
-0.07
0.72
0.10
27.62
102.78
0.2222
16500.00
16500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
882.97
-2.51
33.0
28.0
72.0
164.0
7.0
17.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0109001 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630.0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HCV HIV
Human erythrocytes
13.84 μM
MHC
PaperLi GR, He LY, Liu XY, et al. Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem Biol Drug Des. 2011 Nov;78(5):835-843. doi:10.1111/j.1747-0285.2011.01201.x. PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0195376 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
HCV: inhibition of HCVcc infection in Huh7
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem Biol Drug Des. 2011 Nov;78(5):835-843. doi: 10.1111/j.1747-0285.2011.01201.x. PMID: 21801309. PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0205005 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
cells
1.4±0.13 μM
IC50
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem Biol Drug Des. 2011 Nov;78(5):835-843. doi: 10.1111/j.1747-0285.2011.01201.x. PMID: 21801309. PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0211020 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral Hemolytic
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem Biol Drug Des. 2011 Nov;78(5):835-843. doi: 10.1111/j.1747-0285.2011.01201.x. PMID: 21801309. PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0238307 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
5
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. Chem Biol Drug Des. 2011 Nov;78(5):835-843. doi: 10.1111/j.1747-0285.2011.01201.x. PMID: 21801309. PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
FIRST PREV 1 2 3 NEXT LAST
Showing 5 records on this page · Page 2 of 3